García-Sáez Gema

Dr. García-Sáez Gema


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
LALara Albert
Lara Albert
ICIsmael Capel
Ismael Capel
GGGarcía-Sáez Gema
García-Sáez Gema
PMPablo Martín-Redondo
Pablo Martín-Redondo
MHM. Elena Hernando
M. Elena Hernando
MRMercedes Rigla
Mercedes Rigla

3 August 2020 in Neural Computing and Applications
Verified
Journal Article
Closed access
PDF file
JCJaime Carrillo-Moreno
Jaime Carrillo-Moreno
CPCarmen Pérez-Gandía
Carmen Pérez-Gandía
RSRafael Sendra-Arranz
Rafael Sendra-Arranz
GGGarcía-Sáez Gema
García-Sáez Gema
MHM. Elena Hernando
M. Elena Hernando
Alvaro GutiérrezAlvaro Gutiérrez
Alvaro Gutiérrez

30 July 2024 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
FSFrancisco J. Somolinos-Simón
Francisco J. Somolinos-Simón
GGGarcía-Sáez Gema
García-Sáez Gema
JTJose Tapia-Galisteo
Jose Tapia-Galisteo
RCRosa Corcoy
Rosa Corcoy
MHM. Elena Hernando
M. Elena Hernando
To identify subgroups of adults with type 1 diabetes and analyse their treatment pathways and risk of diabetes-related complications over a 5-year follow-up. We performed a k-means cluster analysis using the T1DExchange Registry (n = 6,302) to identify subgroups based on demographic and clinical characteristics. Annual reassessments linked treatment trajectories with these clusters, considering drug and technology use. Complication risks were analysed using Cox regression. Five clusters were identified: 1) A favourable combination of all variables (31.67 %); 2) Longer diabetes duration (22.63 %); 3) Higher HbA1c levels (13.28 %); 4) Higher BMI (15.25 %); 5) Older age at diagnosis (17.17 %). Two-thirds of patients remained in their initial cluster annually. Technology adoption showed improved glycaemic control over time. Cox proportional hazards showed different risk patterns: Cluster 1 had low complication risk; Cluster 2 had the highest risk for retinopathy, coronary artery disease and autonomic neuropathy; Cluster 3 had the highest risk for albuminuria, depression and diabetic ketoacidosis; Cluster 4 had increased risk for multiple complications; Cluster 5 had the highest risk for hypertension and severe hypoglycaemia, with elevated coronary artery disease risk. Clinical characteristics can identify subgroups of patients with T1DM showing differences in treatment and complications during follow-up.